Motilin-like polypeptides that inhibit gastrointestinal motor activity
CA 2127331 C · Owner: Baxter Pharmaceutical Products Division Inc. · Inventors: Dharanipragada, Ramalinga; Macielag, Mark J.; Marvin, Mary S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention pertains to polypeptides having gastrointestinal motor inhibitory activity represented by the formula: (see above formula I), including optically active isomeric forms and the pharmaceutically acceptable acid, addition salts thereof wherein A is the L-stereoisomer of a lipophilic aliphatic or, alicyclic amino acid; B is selected from the group consisting of L and D aromatic, heteroaromatic, lipophilic aliphatic and alicyclic amino acids; D is the , L-stereoisomer of a lipophilic aliphatic or alicyclic amino acid; E is the L-stereoisomer of an aromatic, aliphatic or alicyclic amino acid; F is the , L-stereoisomer of an aromatic or heteroaromatic amino acid; G is glycine or …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 4, 1994 and granted April 4, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 4, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 4, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.